We are pleased to announce that the meeting “Innovations in Cardiovascular Interventions (ICI) - Leading Technology for Medicine” will be held on December 2-4, 2007 at the Hilton Hotel in Tel-Aviv, Israel.
This meeting is a continuation of the series of international conferences in interventional cardiology held in Israel since 1995, which have helped shape Israel as a leading force in innovative technology in this field.
The upcoming meeting, as the previous one, will be held in collaboration with the Cardiovascular Research Foundation (CRF) and will focus on innovative technology and therapies. The program will include presentations of new therapies and research at various levels of development, with thematic live case presentations to present the impact of these technologies on current and future therapy.
The program will highlight numerous hot topics including drug eluting stents, novel molecular therapeutics, vascular molecular biology, restenosis solutions, adjunctive drug therapy, carotid and valvular interventions, and navigational and guidance percutaneous technologies. Included will be emerging technology sessions, industry-academia discussions, and a review of the regulatory aspects of new devices. Thematic live case demonstrations and clinical overviews on specific topics with an emphasis on future perspectives will be presented by leading international experts.
The venue for the meeting is Tel Aviv, the largest city and biggest commercial center in Israel. Being a busy metropolis, this city inspires visitors with a unique energetic atmosphere of excitement and fun. Tel Aviv’s seafront skyscrapers and exclusive hotels are visible from a distance, presenting a lively combination of entertainment venues, shopping malls, exotic markets, nonstop active nightlife, beautiful golden beaches and all kinds of wonderful restaurants. Tel Aviv is also the country’s greatest cultural center, a home for a variety of museums, galleries, theatres and concert halls.
If you are a clinical cardiologist, an innovative scientist, a biomedical engineer or a major company in this field and want to be part of the future of interventional cardiology, Do not miss this event!
Companies - this is your opportunity to promote your latest innovation.
We look forward to the pleasure of greeting you at what promises to be an exciting and fruitful meeting with a high scientific standard.
